Gene Editing for Everyone: CRISPRware and the Open-Source Biotech Revolution Texas Ban on Lab-Grown Meat Triggers Policy and Legal Showdowns From Early Detection to Tumor “Education”: Syantra’s Bold Bet on cfRNA in Cancer Tech €132M for a Dutch Rare-Disease Upstart: Is Europe Quietly Becoming the New Neurology Capital? From Crypto to Cytoplasm: Brian Armstrong’s NewLimit Targets Hepatocytes for Anti-Aging Breakthrough Fermenting the Future: Inside the Pentagon’s $80 Million Biomanufacturing Bet—and America’s New Industrial Strategy Decoding the 100-Year-Old Code: Inside an Ambitious Quest to Unveil the Genetics of Extreme Longevity Cholesterol Rewritten: Verve’s Base Editing Therapy May Disrupt a $20B Market EU’s €12.5M Bet on Oncomatryx and Antibody-Drug Conjugates (ADCs) Beijing’s Biotech Blitz Is Outpacing America. Washington Needs a War Plan. A Champion Departs: Peter Marks’ Resignation and Biotech’s Crossroads From Collapse to Comeback: Inside Biotech’s ‘Death-to-Rebirth’ Cycle Syngene’s Baltimore Bet: Indian Biotech’s American Ambitions and Global Supply Shake-Up A Champion Departs: Peter Marks’ Resignation and Biotech’s Crossroads Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development Novo Holdings Leads $100 Million Series C Financing for Asceneuron New Study Highlights the Impact of Early-Life Tobacco Exposure on Accelerated Aging Tropic Unveils Gene-Edited Non-Browning Bananas to Reduce Food Waste Metsera’s Weight-Loss Drug MET-097i Shows Strong Clinical Results Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion Marea Biotech Secures $190 Million for Heart Disease Research Manulife and World Economic Forum Launch Longevity Innovation Challenge Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion Light-Based Microcapillary Monitoring Expands Precision in Biotechnology Draupnir Bio Raises €12 Million to Advance Oral Protein Degraders Targeting Extracellular Proteins Novo Holdings Leads $100 Million Series C Financing for Asceneuron German Biotech CatalYm Raises $150 Million for Phase 2b Cancer Studies Myricx Bio’s NMTi-ADCs Achieve Tumor Regression in Preclinical Trials Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion Brisbane Biotech Gelomics Raises $2.2 Million in Pre-Seed Funding Alumis IPO Priced at $16, Targets $210M Funding Unlocking New Frontiers: How Generative AI is Transforming Protein Design and Drug Discovery Manulife and World Economic Forum Launch Longevity Innovation Challenge Impact of Space Travel on Immune Function and Potential Countermeasures UroGen Aims to Raise $107M to Advance Innovative Obesity and Bladder Cancer Therapies Marea Biotech Secures $190 Million for Heart Disease Research Illumina Faces Potential $7 Billion Loss from Forced Grail Sale: An Analysis Revolutionizing Dairy: How Biotech Companies are Producing Milk Without Cows EU Sets New Goals for Advancing Biotechnology and Biomanufacturing Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In STORIES WE THINK YOU MIGHT LIKE AI-Powered Drug Repurposing by BioXcel Therapeutics Accelerates Development of New Neuropsychiatric Treatments CRISPR-Cas9 Enhances Rice Yields Without Introducing Foreign DNA Epigenetic Stability Linked to Lifespan in Mammals, Research Show Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development Limula Secures $6.8M Funding to Enhance Cell and Gene Therapy Manufacturing Forbion-Backed VectorY Therapeutics Raises $138M for ALS and Neurodegenerative Disease Research Epigenetic Stability Linked to Lifespan in Mammals, Research Show Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development Limula Secures $6.8M Funding to Enhance Cell and Gene Therapy Manufacturing Forbion-Backed VectorY Therapeutics Raises $138M for ALS and Neurodegenerative Disease Research Vector Laboratories and Absolute Biotech Announce Merger to Strengthen Life Sciences Capabilities MOST POPULAR Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide Novo Holdings Leads $100 Million Series C Financing for Asceneuron Draupnir Bio Raises €12 Million to Advance Oral Protein Degraders Targeting Extracellular Proteins Light-Based Microcapillary Monitoring Expands Precision in Biotechnology Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies Metsera’s Weight-Loss Drug MET-097i Shows Strong Clinical Results How AI is Revolutionizing Antibiotic Discovery to Combat Drug-Resistant Bacteria AbbVie Enters Obesity Drug Market with $2.2B Gubra Licensing Deal Tropic Unveils Gene-Edited Non-Browning Bananas to Reduce Food Waste Aging Science Impact of Space Travel on Immune Function and Potential Countermeasures Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In Epigenetic Stability Linked to Lifespan in Mammals, Research Show New Study Highlights the Impact of Early-Life Tobacco Exposure on Accelerated Aging Timeline Concludes Major Immune Aging Study with Promising Results See More AI in Biotech How AI is Revolutionizing Antibiotic Discovery to Combat Drug-Resistant Bacteria Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies Unlocking New Frontiers: How Generative AI is Transforming Protein Design and Drug Discovery AI-Powered Drug Repurposing by BioXcel Therapeutics Accelerates Development of New Neuropsychiatric Treatments See More Biotech Stocks Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion Alumis IPO Priced at $16, Targets $210M Funding Diamond Biofund Becomes First Biotech VC Firm Listed on Taiwan Stock Exchange See More CRISPR Gene Editing for Everyone: CRISPRware and the Open-Source Biotech Revolution Cholesterol Rewritten: Verve’s Base Editing Therapy May Disrupt a $20B Market CRISPR-Cas9 Enhances Rice Yields Without Introducing Foreign DNA Innovative Breakthrough in Genomics: Profluent’s OpenCRISPR-1 Revolutionizes Human Genome Editing See More Food Biotech Texas Ban on Lab-Grown Meat Triggers Policy and Legal Showdowns Gene Editing for Everyone: CRISPRware and the Open-Source Biotech Revolution Texas Ban on Lab-Grown Meat Triggers Policy and Legal Showdowns From Early Detection to Tumor “Education”: Syantra’s Bold Bet on cfRNA in Cancer Tech €132M for a Dutch Rare-Disease Upstart: Is Europe Quietly Becoming the New Neurology Capital? See More Funding Draupnir Bio Raises €12 Million to Advance Oral Protein Degraders Targeting Extracellular Proteins Novo Holdings Leads $100 Million Series C Financing for Asceneuron German Biotech CatalYm Raises $150 Million for Phase 2b Cancer Studies Brisbane Biotech Gelomics Raises $2.2 Million in Pre-Seed Funding UroGen Aims to Raise $107M to Advance Innovative Obesity and Bladder Cancer Therapies See More Genomics Epigenetic Stability Linked to Lifespan in Mammals, Research Show Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development AstraZeneca Completes Equity Investment in Cellectis to Enhance Gene Therapy Development Innovative Breakthrough in Genomics: Profluent’s OpenCRISPR-1 Revolutionizes Human Genome Editing See More Insights Fermenting the Future: Inside the Pentagon’s $80 Million Biomanufacturing Bet—and America’s New Industrial Strategy Beijing’s Biotech Blitz Is Outpacing America. Washington Needs a War Plan. A Champion Departs: Peter Marks’ Resignation and Biotech’s Crossroads From Collapse to Comeback: Inside Biotech’s ‘Death-to-Rebirth’ Cycle Syngene’s Baltimore Bet: Indian Biotech’s American Ambitions and Global Supply Shake-Up See More Longevity From Crypto to Cytoplasm: Brian Armstrong’s NewLimit Targets Hepatocytes for Anti-Aging Breakthrough Decoding the 100-Year-Old Code: Inside an Ambitious Quest to Unveil the Genetics of Extreme Longevity The Billionaire Longevity Experiment: A Cruise Ship Promises to Extend Life—For a Price Manulife and World Economic Forum Launch Longevity Innovation Challenge Debate Highlights: Can Aging Be Halted or Reversed? Experts Weigh In See More M&A & Partnerships Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion Orna Therapeutics Acquires ReNAgade Therapeutics to Enhance RNA Medicine Development Vector Laboratories and Absolute Biotech Announce Merger to Strengthen Life Sciences Capabilities See More Neuroscience €132M for a Dutch Rare-Disease Upstart: Is Europe Quietly Becoming the New Neurology Capital? Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery Innovative Study on Addiction by Mount Sinai and Rockefeller University See More News AbbVie Enters Obesity Drug Market with $2.2B Gubra Licensing Deal Metsera’s Weight-Loss Drug MET-097i Shows Strong Clinical Results Light-Based Microcapillary Monitoring Expands Precision in Biotechnology Novo Holdings Leads $100 Million Series C Financing for Asceneuron Myricx Bio’s NMTi-ADCs Achieve Tumor Regression in Preclinical Trials See More
Fermenting the Future: Inside the Pentagon’s $80 Million Biomanufacturing Bet—and America’s New Industrial Strategy
Decoding the 100-Year-Old Code: Inside an Ambitious Quest to Unveil the Genetics of Extreme Longevity
Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery
AI-Powered Drug Repurposing by BioXcel Therapeutics Accelerates Development of New Neuropsychiatric Treatments
Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies
AI-Powered Drug Repurposing by BioXcel Therapeutics Accelerates Development of New Neuropsychiatric Treatments
Fermenting the Future: Inside the Pentagon’s $80 Million Biomanufacturing Bet—and America’s New Industrial Strategy
Decoding the 100-Year-Old Code: Inside an Ambitious Quest to Unveil the Genetics of Extreme Longevity
Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery
